With a market that’s expected to grow from $2 billion in 2020 to $50 billion in only nine years, according to Statista, biotechnology companies are increasingly focused on the development of proprietary systems and procedures to drive research and production of cannabinoid pharmaceuticals.
PotNetwork Holding Inc. recently published estimates by Hemp Business Journal suggesting that hemp-based CBD will be a $1.8 billion market by 2020.
Whether focusing on organic grows or killing the pain of menstrual cramps, these famous folks are lighting up the cannabiz..
Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market projected to reach $135 billion by 2021.
MTRAC enables cannabis suppliers and their customers to complete transactions in a non-cash environment.
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
India Globalization Capital, Inc. (NYSE MKT: IGC) is on the precipice of bringing a potential blockbuster treatment for Alzheimer’s to the market.
Marijuana Company of America (OTC: MCOA) is a unique corporation with a strategic business structure that functions as an umbrella, bringing together a diverse portfolio of investments and joint ventures within the legal cannabis industry.
AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING).
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products.
SinglePoint is very close to launching its own bitcoin exchange aimed at solving the current problems of unbankability for cannabis businesses in the United States.
InMed Pharmaceuticals has developed a proprietary process capable of extracting all 90+ cannabinoids in a laboratory setting.
A noteworthy characteristic of products within this booming sector is bio-absorbability.
Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences.
